Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Peregrine wins new US patent
Peregrine Pharmaceuticals, a biopharmaceutical company, has received a new US patent that is expected to strengthen the company’s intellectual property in the field of phospholipid-targeting agents for the
Peregrine Pharmaceuticals, a biopharmaceutical company, has received a new US patent that is expected to strengthen the company’s intellectual property in the field of phospholipid-targeting agents for the
Orcrist Bio, a biotechnology company developing stem cell-mobilizing pharmaceuticals, has received approval from the European Competent Authority in Seville, Spain for its Phase I, open-label, single-ascending-dose, safety study
Millipore, a life science company, and Novozymes Biopharma, a provider of industrial bio-solutions, have launched CellPrime rAlbumin AF-G, a completely animal-free cell culture supplement designed for large scale
CardioDynamics, a developer and manufacturer of noninvasive ICG diagnostic and monitoring devices and ICG sensors, has reported a net loss of $1.46m, or $0.20 per share for the
Cerapedics, a medical device company, has completed a round of private equity financing totaling $15m. NGN Capital led the round and was joined by sole Series A investor
The National Institutes of Health has said it will consider research proposals comparing the cost-effectiveness of biologic medications, cancer treatments and preventive measures for chronic illnesses such as
Genta, a biopharmaceutical company, has completed patient enrollment in Agenda, a Phase III trial of Genasense injection in patients with advanced melanoma. Final accrual totaled 315 subjects. Agenda
PPD, a contract research organization, has acquired Magen BioSciences, a biotechnology company focused on dermatologic therapies based in Waltham, Massachusetts. Under the terms of the deal, PPD purchased
Dr Reddy’s and Natco would together develop these products for registration and global commercialization including regulated markets of the US and EU. Natco shall exclusively manufacture and supply
Besides enabling a fast and reliable analysis of 2D gel images, the new software called Redfin Solo allows researchers to decide which analyses are worth paying for based